Skip to content

Clinical trials

Enrolling by invitation Leukemia, Myeloid, Acute trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Status: Enrolling by invitation Country / region: China Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20231
20251
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Enrolling by invitation7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
First Affiliated Hospital of Zhejiang University2
Guangdong Second Provincial General Hospital2
Anhui Medical University1
Institute of Hematology & Blood Diseases Hospital, China1
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute7
Neoplasm, Residual2
Leukemia1
Lymphoma, T-Cell1
Myelodysplastic Syndromes1
Precursor Cell Lymphoblastic Leukemia-Lymphoma1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.